tirzepatide in adolescents adolescent obesity trial Efficacy and safety of children and with type 2 diabetes (SURPASS-PEDS): a randomised, double-blind, placebo-controlled, phase 3 Summary of clinical trials that – criteria for tirzepatide Efficacy and

Discontinuation In STEP, 6.8% of people on semaglutide 2.4 mg stopped treatment because of side effects, vs 3.2% on placebo

The trial enrolled 338 adults with obesity (BMI 30) or overweight with comorbidities (BMI 27) and ran for 48 weeks

Experience Check out a clinics track record and how it has helped past clients

At Set Point Medical Weight Loss Clinic, we are committed to providing our patients with the most advanced, evidence-based treatments for sustainable weight management

Due to complications with her health and a high-risk pregnancy, she tragically passed away far too young

The role of free radicals and antioxidants in reproduction